As the COVID-19 pandemic continues, most hospitals have halted all non-emergency visits, greatly affecting the conduct of clinical trials. Below are links to both Health Canada and the US Food and Drug Administration (FDA) guidance on the management of clinical trials during this time, as well as various Canadian research organizations. This post will be updated as more resources come to our attention.
We are working to collect a list of trial resources to help trialist overcome challenges and keep their research program moving forward. If you have had success or suggestions that you can share, please email email@example.com.
Canadian Institutes for Health Research FAQs on Impact of COVID-19 – https://cihr-irsc.gc.ca/e/51917.html#faq
Health Canada Guidance on Management of Clinical Trials during the COVID-19 pandemic – https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html
US FDA Guidance for Clinical Trials during COVID-19 – https://www.fda.gov/media/136238/download
COVID-19 Resources Canada – https://covid19resources.ca/activeresearch.html
Clinical Trials Ontario – https://www.ctontario.ca/covid-19-clinical-trial-resources/
Clinical Trials BC – https://www.clinicaltrialsbc.ca/updates-for-clinical-trials-bc-regarding-covid-19/
Canadian Institute of Health Information (CIHI) – https://www.cihi.ca/en/covid-19-resources